SY - So-Young International Price to Earnings Adjusted for Growth Rate

Corporate company logo of So-Young Corp (SY)

So-Young International generates revenue through commissions and advertising via its scalable aesthetics marketplace. The P/E to expected EPS growth ratio demonstrates the asset's value dynamics, with the metric currently standing at 0.00. However, geopolitical risks in the PRC are weighing on demand. Meanwhile, a stable cloud infrastructure ensures seamless service operation and data processing.

SY So-Young International Inc. Price/Earnings to Growth Multiple (07/04/2022 - 11/14/2026)

Analytical breakdowns for So-Young International (SY)

- market value and analyst target forecast:
- market capitalization statistics:
Summary company analytics:So-Young International Inc, SY
Manufactured products of So-Young International

The PEG ratio correlates the P/E multiple with earnings growth rates, allowing for the determination of an asset's fair value relative to its expansion. By analyzing the dynamics of the PEG undervaluation indicator, an investor identifies the gap between the price and the actual development of So-Young International (SY), which is critical for the cyclical aesthetic medicine business that is sensitive to changes in the disposable income of China's population.

Competing companies

Veeva Systems (VEEV) - Price to Net Income Growth Ratio|Doximity Corp - Price/Earnings to Growth Multiple|HealthEquity Building (HQY) - Price to Earnings Adjusted for Growth Rate|WAY - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate corvel.com|PRVA (Privia Health) - Price/Earnings to Growth Multiple|Huron Consulting Group Inc. (HURN) - PEG Multiple|Price/Earnings to Growth Ratio Certara Corp|Growth-Adjusted P/E Ratio OMCL (Omnicell Health)|PEG Multiple GDRX|schrodinger.com (SDGR) - Price to Net Income Growth Ratio|Phreesia - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio OMDA|Evolent - PEG Multiple|Growth-Adjusted Market Cap to Net Income HealthStream Learning HSTM|Definitive Healthcare (DH) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio CCSI|Price/Earnings to Growth Multiple AGL|ABSI (Absci Corp) - Company Value to Earnings Growth Ratio|PEG Multiple NRC|SPOK - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio OptimizeRx Corporation OPRX|Growth-Adjusted Payback Ratio TBRG|SLP - Price/Earnings to Growth Ratio|SOPH (SOPHiA GENETICS SA) - Growth-Adjusted P/E Ratio|HCAT: PEG Multiple|CareCloud (CCLD) - PEG Multiple|Price/Earnings to Growth Multiple RSSS|DLHC (DLH Holdings Corp) - Company Value to Earnings Growth Ratio|PEG Multiple ONMD|Growth-Adjusted Market Cap to Net Income Scienture Holdings|Price/Earnings to Growth Ratio Healthcare Triangle Corp HCTI|iSpecimen Inc (ISPC) - Price to Earnings Adjusted for Growth Rate|BFRG - Price/Earnings to Growth Ratio|WORX (scworx.com) - Growth-Adjusted P/E Ratio|MSPR: PEG Multiple|iCoreConnect (ICCT) - PEG Multiple|Price/Earnings to Growth Ratio TRxADE|Price/Earnings to Growth Ratio ORGS|Price/Earnings to Growth Ratio R1 RCM Inc. (RCM)|Growth-Adjusted Market Cap to Net Income sharecare.com|Streamline Health - Price/Earnings to Growth Multiple|Syra Health Corp (SYRA) - Price to Earnings Adjusted for Growth Rate|ApolloMed - PEG Multiple|Growth-Adjusted Market Cap to Net Income Model N Corporation MODN|NXGN (NextGen Healthcare) - Price/Earnings to Growth Multiple